|
1
|
Schuppan D and Afdhal NH: Liver cirrhosis.
Lancet. 371:838–851. 2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Iwakiri Y, Shah V and Rockey DC: Vascular
pathobiology in chronic liver disease and cirrhosis-current status
and future directions. J Hepatol. 61:912–924. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Iwakiri Y: Pathophysiology of portal
hypertension. Clin Liver Dis. 18:281–291. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Benz F, Mohr R, Tacke F and Roderburg C:
Pulmonary complications in patients with liver cirrhosis. J Transl
Int Med. 8:150–158. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sood G, Fallon MB, Niwas S, Tutton T, Van
Leeuwen DJ, Bloomer JR and McGuire BM: Utility of a dyspnea-fatigue
index for screening liver transplant candidates for hepatopulmonary
syndrome [abstract]. Hepatolog. 28 (Suppl)(S742)1998.
|
|
6
|
Hourani JM, Bellamy PE, Tashkin DP, Batra
P and Simmons MS: Pulmonary dysfunction in advanced liver disease:
Frequent occurrence of an abnormal diffusing capacity. Am J Med.
90:693–700. 1991.PubMed/NCBI
|
|
7
|
Fallon MB and Abrams GA: Pulmonary
dysfunction in chronic liver disease. Hepatology. 32:859–865.
2000.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Møller S, Krag A, Henriksen JH and
Bendtsen F: Pathophysiological aspects of pulmonary complications
of cirrhosis. Scand J Gastroenterol. 42:419–427. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Miller MR, Crapo R, Hankinson J, Brusasco
V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP,
Gustafsson P, et al: General considerations for lung function
testing. Eur Respir J. 26:153–161. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Georgakopoulou VE, Tarantinos K, Papalexis
P, Spandidos DA, Damaskos C, Gkoufa A, Chlapoutakis S, Sklapani P,
Trakas N and Mermigkis D: Role of pulmonary function testing in
inflammatory bowel diseases (review). Med Int (Lond).
2(25)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Roque L, Sankarankutty AK, Silva OC Jr and
Mente ED: Evaluation of lung function in liver transplant
candidates. Transplant Proc. 50:762–765. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yao EH, Kong BC, Hsue GL, Zhou AC and Wang
H: Pulmonary function changes in cirrhosis of the liver. Am J
Gastroenterol. 82:352–354. 1987.PubMed/NCBI
|
|
13
|
Awad NF, Elbalsha AAM, Amer MZA and
Ibrahim MHE: Study of the relationship between severity of liver
cirrhosis and pulmonary function tests. Egypt J Hosp Med.
76:4570–4576. 2019.
|
|
14
|
Whitelaw WA, Derenne JP and Milic-Emili J:
Occlusion pressure as a measure of respiratory center output in
conscious man. Respir Physiol. 23:181–199. 1975.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gholamipoor D, Nassiri-Toosi M, Azadi M
and Asadi Gharabaghi M: The relationship between airway occlusion
pressure and severity of liver cirrhosis in candidates for liver
transplantation. Middle East J Dig Dis. 12:111–115. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Graham BL, Steenbruggen I, Miller MR,
Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA,
McCarthy K, McCormack MC, et al: Standardization of spirometry 2019
update. An official American thoracic society and european
respiratory society technical statement. Am J Respir Crit Care Med.
200:e70–e88. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Riley CM, Wenzel SE, Castro M, Erzurum SC,
Chung KF, Fitzpatrick AM, Gaston B, Israel E, Moore WC, Bleecker
ER, et al: Clinical implications of having reduced mid forced
expiratory flow rates (FEF25-75), independently of FEV1, in adult
patients with asthma. PLoS One. 10(e0145476)2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hara N, Yoshida T, Furukawa T and Inokuchi
K: Abnormalities in maximum flow volume curve and closing volume in
patients with hepatic cirrhosis. Jpn J Surg. 10:265–269.
1980.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Caruso G, Catalano D, Corsaro A, Salerno
M, Sciuto L, Sciuto V and Mazzone O: Respiratory function and liver
cirrhosis. Riv Eur Sci Med Farmacol. 12:83–89. 1990.PubMed/NCBI
|
|
20
|
Nagral A, Kolhatkar VP, Bhatia SJ, Taskar
VS and Abraham P: Pulmonary function tests in cirrhotic and
non-cirrhotic portal hypertension. Indian J Gastroenterol.
12:36–40. 1993.PubMed/NCBI
|
|
21
|
Al-Moamary MS, Gorka T, Al-Traif IH,
Al-Jahdali HH, Al-Shimemeri AA, Al-Kanway B and Abdulkareeem AA and
Abdulkareeem AA: Pulmonary changes in liver transplant candidates
with hepatitis C cirrhosis. Saudi Med J. 22:1069–1072.
2001.PubMed/NCBI
|
|
22
|
Tüzün A, Uzun K, Yüksekol I and Taş D:
Evaluation of pulmonary function tests in end stage liver diseases.
Solunum. 3:117–120. 2001.
|
|
23
|
Yigit IP, Hacievliyagil SS, Seckin Y, Oner
RI and Karincaoglu M: The relationship between severity of liver
cirrhosis and pulmonary function tests. Dig Dis Sci. 53:1951–1956.
2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Drenth JPH, Jansen JBMJ and Dekhuijzen
PNR: Reduced diffusion in liver cirrhosis is related to impairment
of protein liver synthesis. Scand J Gastroenterol. 37:1338–1340.
2002.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bozbas SS, Yilmaz EB, Dogrul I, Ergur FO,
Savas N, Eyuboglu F and Haberal M: Preoperative pulmonary
evaluation of liver transplant candidates: Results from 341 adult
patients. Ann Transplant. 16:88–96. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ghayumi SM, Mehrabi S, Zamirian M, Haseli
J and Bagheri Lankarani K: Pulmonary complications in cirrhotic
candidates for liver transplantation. Hepat Mon. 10:105–109.
2010.PubMed/NCBI
|
|
27
|
Siemieniako A, Pogorzelska J, Łapiński TW
and Flisiak R: Respiratory functional impairment in patients with
liver cirrhosis. Pol Merkur Lekarski. 31:274–277. 2011.PubMed/NCBI(In Polish).
|
|
28
|
Corlateanu O, Tcaciuc E and Corlateanu A:
Evaluation of pulmonary function and functional capacity in
patients with liver cirrhosis. Eur Respir J. 40 (Suppl
56)(P588)2012.
|
|
29
|
Thenmozhi R, Ratna Manjushree J, Heber A
and Vishwanatha RB: Pulmonary functions and respiratory efficiency
in patients with cirrhosis and portal hypertension. Int J Sci
Study. 4:114–117. 2016.
|
|
30
|
Osni Leão Perin P, de Fátma Ferreira
Santana Boin I, Oliveira da Silva AM, Chueiri Neto F and Martins
LC: Lung ultrasound and pulmonary function test in cirrhotic
patients. Transplant Proc. 49:824–828. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shahzad M, Iqbal J, Imran Aslam M, Tahir
M, Javed M and Ashfaq Zia M: Examine the association between
patients of liver cirrhosis and pulmonary dysfunctions. PJMHS.
13:573–575. 2019.
|
|
32
|
Alkhayat K, Moustafa G, Zaghloul A and
Elazeem AA: Pulmonary dysfunction in patients with liver cirrhosis.
Arch Med. 9(4)2017.
|
|
33
|
DuBrock HM, Krowka MJ, Krok K, Forde K,
Mottram C, Scanlon P, Al-Naamani N, Patel M, McCormick A, Fallon MB
and Kawut SM: Prevalence and impact of restrictive lung disease in
liver transplant candidates. Liver Transpl. 26:989–999.
2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Makhlouf NA, Mahran ZG, Sadek SH, Magdy DM
and Makhlouf HA: Six-minute walk test before and after large-volume
paracentesis in cirrhotic patients with refractory ascites: A pilot
study. Arab J Gastroenterol. 20:81–85. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kaltsakas G, Antoniou E, Palamidas AF,
Gennimata SA, Paraskeva P, Smyrnis A, Koutsoukou A, Milic-Emili J
and Koulouris NG: Dyspnea and respiratory muscle strength in
end-stage liver disease. World J Hepatol. 5:56–63. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mizuno Y, Ito S, Hattori K, Nagaya M,
Inoue T, Nishida Y, Onishi Y, Kamei H, Kurata N, Hasegawa Y and
Ogura Y: Changes in muscle strength and six-minute walk distance
before and after living donor liver transplantation. Transplant
Proc. 48:3348–3355. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Nitrini AMS, Rolim EG and Stirbulov R:
Influence of ascites on pulmonary function in patients with portal
hypertension. J Bras Pneumol. 30:1–9. 2004.
|
|
38
|
Kia L, Cuttica MJ, Yang A, Donnan EN,
Whitsett M, Singhvi A, Lemmer A and Levitsky J: The utility of
pulmonary function testing in predicting outcomes following liver
transplantation. Liver Transpl. 22:805–811. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Demirel S, Funda Coskun N, Giray Nak S and
Ozyener F: Assessment of pulmonary functions with spirometry method
in hepatic impairment patients. Ann Med Res. 28:1–7. 2021.
|
|
40
|
Zuberi FF, Zuberi BF, Rasheed T and Nawaz
Z: Non-specific impairment of lung function on spirometery in
patients with chronic hepatitis-C. Pak J Med Sci. 35:360–364.
2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Enright Md P: Office-based DLCO tests help
pulmonologists to make important clinical decisions. Respir
Investig. 54:305–311. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Degano B, Mittaine M, Guénard H, Rami J,
Garcia G, Kamar N, Bureau C, Péron JM, Rostaing L and Rivière D:
Nitric oxide and carbon monoxide lung transfer in patients with
advanced liver cirrhosis. J Appl Physiol (1985). 107:139–143.
2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Jung JY, Jun DW and Lee JH: Lung diffusion
capacity in early cirrhosis: Is lung diffusion capacity a predictor
of esophageal varices and ascites? Dig Dis Sci. 56:1229–1234.
2011.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Park MS, Lee MH, Park YS, Kim SH, Kwak MJ
and Kang JS: Abnormal gas diffusing capacity and portosystemic
shunt in patients with chronic liver disease. Gastroenterology Res.
5:182–189. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
45
|
O'Donnell CR, Bankier AA, Stiebellehner L,
Reilly JJ, Brown R and Loring SH: Comparison of plethysmographic
and helium dilution lung volumes: Which is best for COPD? Chest.
137:1108–1115. 2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hopkins E and Sharma S: Physiology,
functional residual capacity. [Updated 2022 Jan 4]. In: StatPearls
[Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
Available from: https://www.ncbi.nlm.nih.gov/books/NBK500007/.
|
|
47
|
Lover MB: Cirrhosis and regional lung
function. Anesthesiology. 36(527)1972.
|
|
48
|
Milic-Emili J, Torchio R and D'Angelo E:
Closing volume: A reappraisal (1967-2007). Eur J Appl Physiol.
99:567–583. 2007.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Veneroni C, Van Muylem A, Malinovschi A,
Michils A and Dellaca' RL: Closing volume detection by
single-breath gas washout and forced oscillation technique. J Appl
Physiol (1985). 130:903–913. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ruff F, Hughes JM, Stanley N, McCarthy D,
Greene R, Aronoff A, Clayton L and Milic-Emili J: Regional lung
function in patients with hepatic cirrhosis. J Clin Invest.
50:2403–2413. 1971.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kuhlen R, Mohnhaupt R, Slama K, Hausmann
S, Pappert D, Rossaint R and Falke K: Validation and clinical
application of a continuous P0.1 measurement using standard
respiratory equipment. Technol Health Care. 4:415–424.
1996.PubMed/NCBI
|
|
52
|
Evans JA and Whitelaw WA: The assessment
of maximal respiratory mouth pressures in adults. Respir Care.
54:1348–1359. 2009.PubMed/NCBI
|
|
53
|
Corrêa FCCR, Mira PAC, Pace FHL, Laterza
MC, Trevizan PF and Martinez DG: Reduced peripheral and inspiratory
muscle endurance in patients with liver cirrhosis: A
cross-sectional study. Arq Gastroenterol. 58:308–315.
2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Faustini Pereira JL, Galant LH, Rossi D,
Telles da Rosa LH, Garcia E, de Mello Brandão AB and Marroni CA:
Functional capacity, respiratory muscle strength, and oxygen
consumption predict mortality in patients with cirrhosis. Can J
Gastroenterol Hepatol. 2016(6940374)2016.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Galant LH, Forgiarini Junior LA, Dias AS
and Marroni CA: Functional status, respiratory muscle strength, and
quality of life in patients with cirrhosis. Rev Bras Fisioter.
16:30–34. 2012.PubMed/NCBI(In English, Portuguese).
|
|
56
|
Taylor DR, Pijnenburg MW, Smith AD and De
Jongste JC: Exhaled nitric oxide measurements: Clinical application
and interpretation. Thorax. 61:817–827. 2006.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Sogni P, Garnier P, Gadano A, Moreau R,
Dall'Ava-Santucci J, Dinh-Xuan AT and Lebrec D: Endogenous
pulmonary nitric oxide production measured from exhaled air is
increased in patients with severe cirrhosis. J Hepatol. 23:471–473.
1995.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Rolla G, Brussino L, Colagrande P,
Scappaticci E, Morello M, Bergerone S, Ottobrelli A, Cerutti E,
Polizzi S and Bucca C: Exhaled nitric oxide and impaired
oxygenation in cirrhotic patients before and after liver
transplantation. Ann Intern Med. 129:375–378. 1998.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Söderman C, Leone A, Furst V and Persson
MG: Endogenous nitric oxide in exhaled air from patients with liver
cirrhosis. Scand J Gastroenterol. 32:591–597. 1997.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Delclaux C, Mahut B, Zerah-Lancner F,
Delacourt C, Laoud S, Cherqui D, Duvoux C, Mallat A and Harf A:
Increased nitric oxide output from alveolar origin during liver
cirrhosis versus bronchial source during asthma. Am J Respir Crit
Care Med. 165:332–337. 2002.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Matsumoto A, Ogura K, Hirata Y, Kakoki M,
Watanabe F, Takenaka K, Shiratori Y, Momomura S and Omata M:
Increased nitric oxide in the exhaled air of patients with
decompensated liver cirrhosis. Ann Intern Med. 123:110–113.
1995.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Degano B, Mittaine M, Hervé P, Rami J,
Kamar N, Suc B, Rivière D and Rostaing L: Nitric oxide production
by the alveolar compartment of the lungs in cirrhotic patients. Eur
Respir J. 34:138–144. 2009.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Lam Shin Cheung J, Naimi M, Sykes J and
Gupta S: A role for alveolar exhaled nitric oxide measurement in
the diagnosis of hepatopulmonary syndrome. J Clin Gastroenterol.
54:278–283. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Huang X, Thansamay S, Yang K, Luo T and
Chen S: Measurement of exhaled nitric oxide in cirrhotic patients
with esophageal and gastric varices. Biomed Res Int.
2019(9673162)2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Hulo S, Edme JL, Inamo J, Van Bulck R,
Dharancy S and Neviere R: Elevated alveolar nitric oxide is linked
to poor aerobic capacity and chronotropic incompetence in liver
transplant candidates. J Breath Res. 12(046008)2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Neviere R, Trinh-Duc P, Hulo S, Edme JL,
Dehon A, Boleslawski E, Dharancy S and Lebuffe G: Predictive value
of exhaled nitric oxide and aerobic capacity for sepsis
complications after liver transplantation. Transpl Int.
29:1307–1316. 2016.PubMed/NCBI View Article : Google Scholar
|
|
67
|
El-Shabrawi MHF, El-Karaksy HM, Okasha SH,
El-Sayed HM, Kotb MA, Hassan AM and Ibrahim AM: Pulmonary function
testing in children with chronic liver disease. Alex J Pediatr.
16:405–409. 2002.
|
|
68
|
Alves L, Sant'Anna CC, March Mde F,
Ferreira S, Marsillac M, Tura M and Oñate H: Preoperative pulmonary
assessment of children for liver transplantation. Pediatr
Transplant. 12:536–540. 2008.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Dehghani SM, Aleyasin S, Honar N,
Eshraghian A, Kashef S, Haghighat M and Malek-Hosseini SA:
Pulmonary evaluation in pediatric liver transplant candidates.
Indian J Pediatr. 78:171–175. 2011.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Vespasiani-Gentilucci U, De Vincentis A,
Ferrucci L, Bandinelli S, Antonelli Incalzi R and Picardi A: Low
alanine aminotransferase levels in the elderly population: Frailty,
disability, sarcopenia, and reduced survival. J Gerontol A Biol Sci
Med Sci. 73:925–930. 2018.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Lee HW, Chung GE, Koo BK, Sim H, Choi M,
Lee DH, Choi SH, Kwak SH, Kim DK and Kim W: Innovative Target
Exploration of NAFLD (ITEN) consortium. Impact of evolutionary
changes in nonalcoholic fatty liver disease on lung function
decline. Gut Liver. 17:139–149. 2023.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Forno E, Han YY, Muzumdar RH and Celedón
JC: Insulin resistance, metabolic syndrome, and lung function in US
adolescents with and without asthma. J Allergy Clin Immunol.
136:304–311.e8. 2015.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Kim SH, Kim HS, Min HK and Lee SW:
Association between insulin resistance and lung function trajectory
over 4 years in South Korea: Community-based prospective cohort.
BMC Pulm Med. 21(110)2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Wang MT, Lai JH, Huang YL, Kuo FC, Wang
YH, Tsai CL and Tu MY: Use of antidiabetic medications and risk of
chronic obstructive pulmonary disease exacerbation requiring
hospitalization: A disease risk score-matched nested case-control
study. Respir Res. 21(319)2020.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Baffi CW, Wood L, Winnica D, Strollo PJ
Jr, Gladwin MT, Que LG and Holguin F: Metabolic syndrome and the
lung. Chest. 149:1525–1534. 2016.
|
|
76
|
Wu H and Ballantyne CM: Metabolic
Inflammation and insulin resistance in obesity. Circ Res.
126:1549–1564. 2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Kalhan R, Tran BT, Colangelo LA, Rosenberg
SR, Liu K, Thyagarajan B, Jacobs DR Jr and Smith LJ: Systemic
inflammation in young adults is associated with abnormal lung
function in middle age. PLoS One. 5(e11431)2010.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Hughes JM and Rosenzweig DY: Factors
affecting trapped gas volume in perfused dog lungs. J Appl Physiol.
29:332–339. 1970.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Lemen R, Jones JG, Graf PD and Cowan G:
‘Closing volume’ changes in alloxan-induced pulmonary edema in
anesthetized dogs. J Appl Physiol. 39:235–241. 1975.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Rüttner JR, Bärtschi JP, Niedermann R and
Schneider J: Plexogenic pulmonary arteriopathy and liver cirrhosis.
Thorax. 35:133–136. 1980.PubMed/NCBI View Article : Google Scholar
|
|
81
|
McDonnell PJ, Toye PA and Hutchins GM:
Primary pulmonary hypertension and cirrhosis: Are they related? Am
Rev Respir Dis. 127:437–441. 1983.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Golding PL, Smith M and Williams R:
Multisystem involvement in chronic liver disease. Studies on the
incidence and pathogenesis. Am J Med. 55:772–782. 1973.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Matsubara O, Nakamura T, Uehara T and
Kasuga T: Histometrical investigation of the pulmonary artery in
severe hepatic disease. J Pathol. 143:31–37. 1984.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Rodriguez-Roisin R, Pares A, Bruguera M,
Coll J, Picado C, Agusti-Vidal A, Burgos F and Rodes J: Pulmonary
involvement in primary biliary cirrhosis. Thorax. 36:208–212.
1981.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Segal I, Fink G, Machtey I, Gura V and
Spitzer SA: Pulmonary function abnormalities in Sjögren's syndrome
and the sicca complex. Thorax. 36:286–289. 1981.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Krowka MJ and Cortese DA: Pulmonary
aspects of chronic liver disease and liver transplantation. Mayo
Clin Proc. 60:407–418. 1985.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Ji FP, Li ZX, Deng H, Xue HA, Liu Y and Li
M: Diagnosis and management of interstitial pneumonitis associated
with interferon therapy for chronic hepatitis C. World J
Gastroenterol. 16:4394–4399. 2010.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Robin ED, Horn B, Goris ML, Theodore J,
Kessel AV, Mazoub J and Tilkian A: Detection, quantitation and
pathophysiology of lung ‘spiders’. Trans Assoc Am Physicians.
88:202–216. 1975.PubMed/NCBI
|
|
89
|
Henriksen JH, Bendtsen F and Møller S:
Acid-base disturbance in patients with cirrhosis: Relation to
hemodynamic dysfunction. Eur J Gastroenterol Hepatol. 27:920–927.
2015.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Jiménez JV, Carrillo-Pérez DL,
Rosado-Canto R, García-Juárez I, Torre A, Kershenobich D and
Carrillo-Maravilla E: Electrolyte and acid-base disturbances in
end-stage liver disease: A physiopathological approach. Dig Dis
Sci. 62:1855–1871. 2017.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Passino C, Giannoni A, Mannucci F,
Prontera C, Filipponi F, Carrai P, Emdin M and Catapano G: Abnormal
hyperventilation in patients with hepatic cirrhosis: Role of
enhanced chemosensitivity to carbon dioxide. Int J Cardiol.
154:22–26. 2012.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Scheiner B, Lindner G, Reiberger T,
Schneeweiss B, Trauner M, Zauner C and Funk GC: Acid-base disorders
in liver disease. J Hepatol. 67:1062–1073. 2017.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Clague JE, Carter J, Pearson MG and
Calverley PM: Effect of sustained inspiratory loading on
respiratory sensation and CO2 responsiveness in normal humans. Clin
Sci (Lond). 91:513–518. 1996.PubMed/NCBI View Article : Google Scholar
|
|
94
|
El-Gamal H, Khayat A, Shikora S and
Unterborn JN: Relationship of dyspnea to respiratory drive and
pulmonary function tests in obese patients before and after weight
loss. Chest. 128:3870–3874. 2005.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Huang CH, Martin AD and Davenport PW:
Effect of inspiratory muscle strength training on inspiratory motor
drive and RREP early peak components. J Appl Physiol (1985).
94:462–468. 2003.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Moreau R and Lebrec D: Endogenous factors
involved in the control of arterial tone in cirrhosis. J Hepatol.
22:370–376. 1995.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Angueira CE and Kadakia SC: Effects of
large-volume paracentesis on pulmonary function in patients with
tense cirrhotic ascites. Hepatology. 20:825–828. 1994.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Berkowitz KA, Butensky MS and Smith RL:
Pulmonary function changes after large volume paracentesis. Am J
Gastroenterol. 88:905–907. 1993.PubMed/NCBI
|
|
99
|
Chao Y, Wang SS, Lee SD, Shiao GM, Chang
HI and Chang SC: Effect of large-volume paracentesis on pulmonary
function in patients with cirrhosis and tense ascites. J Hepatol.
20:101–105. 1994.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Chang SC, Chang HI, Chen FJ, Shiao GM,
Wang SS and Lee SD: Therapeutic effects of diuretics and
paracentesis on lung function in patients with non-alcoholic
cirrhosis and tense ascites. J Hepatol. 26:833–838. 1997.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Geoum MS, Kim YT, Choi SG, Lee CH, Kweon
YO, Kim SK, Choi YH and Chung JM: The effect of paracentesis on
pulmonary function in patients with cirrhosis. Korean J Hepatol.
3:50–57. 1997.
|
|
102
|
Duranti R, Laffi G, Misuri G, Riccardi D,
Gorini M, Foschi M, Iandelli I, Mazzanti R, Mancini M, Scano G and
Gentilini P: Respiratory mechanics in patients with tense cirrhotic
ascites. Eur Respir J. 10:1622–1630. 1997.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Gupta D, Lalrothuama Agrawal PN, Aggarwal
AN, Dhiman RK, Behera D and Chawla Y: Pulmonary function changes
after large volume paracentesis. Trop Gastroenterol. 21:68–70.
2000.PubMed/NCBI
|
|
104
|
Limongi V, dos Santos DC, da Silva AM,
Ataide EC, Mei MF, Udo EY, Boin IF and Stucchi RS: Effects of a
respiratory physiotherapeutic program in liver transplantation
candidates. Transplant Proc. 46:1775–1777. 2014.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Ewert R, Mutze S, Schachschal G, Lochs H
and Plauth M: High prevalence of pulmonary diffusion abnormalities
without interstitial changes in long-term survivors of liver
transplantation. Transpl Int. 12:222–228. 1999.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Battaglia SE, Pretto JJ, Irving LB, Jones
RM and Angus PW: Resolution of gas exchange abnormalities and
intrapulmonary shunting following liver transplantation.
Hepatology. 25:1228–1232. 1997.PubMed/NCBI View Article : Google Scholar
|
|
107
|
European Association for the Study of the
Liver. Electronic address: simpleeasloffice@easloffice.eu.
EASL clinical practice guidelines: Liver transplantation. J
Hepatol. 64:433–485. 2016.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Lima BLG, França AVC, Pazin-Filho A,
Araújo WM, Martinez JAB, Maciel BC, Simões MV, Terra-Filho J and
Martinelli ALC: Frequency, clinical characteristics, and
respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc.
79:42–48. 2004.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Khiangte B, Kothakota SR, Sasidharan M,
Kareem H, Joshi S, Kumar VV, Kanala JR, Kumar CP and Nair AK:
Prevalence and determinants of hepatopulmonary syndrome in
decompensated chronic liver disease. Indian J Gastroenterol.
39:362–369. 2020.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Martínez GP, Barberà JA, Visa J, Rimola A,
Paré JC, Roca J, Navasa M, Rodés J and Rodriguez-Roisin R:
Hepatopulmonary syndrome in candidates for liver transplantation. J
Hepatol. 34:651–657. 2001.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Buggs J, LaGoy M, Ermekbaeva A, Rogers E,
Nyce S, Patiño D, Kumar A and Kemmer N: Cost utilization and the
use of pulmonary function tests in preoperative liver transplant
patients. Am Surg. 86:996–1000. 2020.PubMed/NCBI View Article : Google Scholar
|
